持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/09/18 | 4,185 | 4,185 | 4,095 | 4,125 | -65 | -1.6% | 37,800 |
2019/09/17 | 4,190 | 4,195 | 4,160 | 4,190 | ±0 | ±0% | 44,600 |
2019/09/13 | 4,170 | 4,200 | 4,110 | 4,190 | +65 | +1.6% | 88,400 |
2019/09/12 | 4,190 | 4,200 | 4,110 | 4,125 | +30 | +0.7% | 60,700 |
2019/09/11 | 4,035 | 4,105 | 4,000 | 4,095 | +70 | +1.7% | 56,300 |
2019/09/10 | 4,040 | 4,040 | 3,990 | 4,025 | +10 | +0.2% | 63,200 |
2019/09/09 | 4,040 | 4,040 | 4,000 | 4,015 | -5 | -0.1% | 36,800 |
2019/09/06 | 4,085 | 4,085 | 4,005 | 4,020 | -75 | -1.8% | 38,100 |
2019/09/05 | 4,050 | 4,135 | 4,030 | 4,095 | +75 | +1.9% | 71,900 |
2019/09/04 | 4,050 | 4,085 | 4,020 | 4,020 | -10 | -0.2% | 38,900 |
2019/09/03 | 3,990 | 4,050 | 3,980 | 4,030 | +5 | +0.1% | 31,500 |
2019/09/02 | 4,145 | 4,150 | 4,020 | 4,025 | -125 | -3% | 34,900 |
2019/08/30 | 4,050 | 4,160 | 4,040 | 4,150 | +155 | +3.9% | 85,800 |
2019/08/29 | 4,005 | 4,040 | 3,945 | 3,995 | -5 | -0.1% | 43,700 |
2019/08/28 | 4,070 | 4,070 | 4,000 | 4,000 | -60 | -1.5% | 34,200 |
2019/08/27 | 4,070 | 4,125 | 4,055 | 4,060 | +35 | +0.9% | 36,500 |
2019/08/26 | 4,015 | 4,070 | 4,010 | 4,025 | -120 | -2.9% | 71,500 |
2019/08/23 | 4,115 | 4,160 | 4,070 | 4,145 | +40 | +1% | 46,400 |
2019/08/22 | 4,180 | 4,180 | 4,085 | 4,105 | -65 | -1.6% | 53,900 |
2019/08/21 | 4,190 | 4,215 | 4,150 | 4,170 | -85 | -2% | 35,400 |
2019/08/20 | 4,205 | 4,255 | 4,175 | 4,255 | +50 | +1.2% | 34,400 |
2019/08/19 | 4,255 | 4,255 | 4,190 | 4,205 | -5 | -0.1% | 24,500 |
2019/08/16 | 4,195 | 4,240 | 4,170 | 4,210 | +15 | +0.4% | 43,000 |
2019/08/15 | 4,190 | 4,195 | 4,150 | 4,195 | -65 | -1.5% | 44,600 |
2019/08/14 | 4,255 | 4,300 | 4,220 | 4,260 | +15 | +0.4% | 42,000 |
2019/08/13 | 4,255 | 4,280 | 4,215 | 4,245 | -70 | -1.6% | 40,600 |
2019/08/09 | 4,330 | 4,385 | 4,305 | 4,315 | +20 | +0.5% | 33,500 |
2019/08/08 | 4,325 | 4,325 | 4,265 | 4,295 | -30 | -0.7% | 41,100 |
2019/08/07 | 4,330 | 4,355 | 4,290 | 4,325 | -50 | -1.1% | 62,200 |
2019/08/06 | 4,335 | 4,375 | 4,285 | 4,375 | -80 | -1.8% | 69,300 |
2019/08/05 | 4,430 | 4,520 | 4,370 | 4,455 | -175 | -3.8% | 93,900 |
2019/08/02 | 4,540 | 4,675 | 4,530 | 4,630 | +40 | +0.9% | 110,000 |
2019/08/01 | 4,590 | 4,595 | 4,520 | 4,590 | +5 | +0.1% | 50,200 |
2019/07/31 | 4,545 | 4,625 | 4,540 | 4,585 | -15 | -0.3% | 61,200 |
2019/07/30 | 4,590 | 4,605 | 4,545 | 4,600 | ±0 | ±0% | 61,000 |
2019/07/29 | 4,675 | 4,675 | 4,555 | 4,600 | -55 | -1.2% | 34,500 |
2019/07/26 | 4,700 | 4,700 | 4,635 | 4,655 | +5 | +0.1% | 45,900 |
2019/07/25 | 4,655 | 4,670 | 4,625 | 4,650 | ±0 | ±0% | 44,800 |
2019/07/24 | 4,675 | 4,675 | 4,615 | 4,650 | -15 | -0.3% | 57,800 |
2019/07/23 | 4,650 | 4,685 | 4,620 | 4,665 | ±0 | ±0% | 39,500 |
2019/07/22 | 4,675 | 4,740 | 4,650 | 4,665 | -50 | -1.1% | 44,600 |
2019/07/19 | 4,620 | 4,720 | 4,610 | 4,715 | +95 | +2.1% | 48,600 |
2019/07/18 | 4,735 | 4,735 | 4,605 | 4,620 | -145 | -3% | 59,800 |
2019/07/17 | 4,730 | 4,785 | 4,720 | 4,765 | +25 | +0.5% | 39,200 |
2019/07/16 | 4,735 | 4,760 | 4,710 | 4,740 | -45 | -0.9% | 32,400 |
2019/07/12 | 4,765 | 4,790 | 4,715 | 4,785 | -5 | -0.1% | 30,400 |
2019/07/11 | 4,735 | 4,820 | 4,735 | 4,790 | +85 | +1.8% | 50,200 |
2019/07/10 | 4,680 | 4,720 | 4,635 | 4,705 | +5 | +0.1% | 53,800 |
2019/07/09 | 4,785 | 4,805 | 4,685 | 4,700 | -50 | -1.1% | 48,800 |
2019/07/08 | 4,830 | 4,835 | 4,745 | 4,750 | -100 | -2.1% | 41,800 |
1451~
1500
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 311,500円 | +5.1% | -7.0% | 2.57% | 20.45倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
東和薬品 | 311,500円 | +7.9% | -3.3% | 2.57% | 8.66倍 | 0.89倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 204,700円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
栄研化 | 241,900円 | +4.1% | -3.1% | 2.40% | 21.01倍 | 1.83倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム